Johannes Streffer, MD

Articles by Johannes Streffer, MD

Episode 158: Bexicaserin, the PACIFIC Trial, and Treating Developmental Epileptic Encephalopathies

January 9th 2026

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Johannes Streffer, MD. [LISTEN TIME: 14 minutes]

Clinical Insights on the Long-Term Efficacy, Safety Profile of Bexicaserin in Developmental Epileptic Encephalopathies: Johannes Streffer, MD

ByJohannes Streffer, MD

December 16th 2025

The senior vice president of clinical development for Lundbeck provided in-depth commentary on the mechanism of bexicaserin, and the promising early-stage data shown in those with developmental epileptic encephalopathies. [WATCH TIME: 4 minutes]

Johannes Streffer, MD

Articles by Johannes Streffer, MD

Episode 158: Bexicaserin, the PACIFIC Trial, and Treating Developmental Epileptic Encephalopathies

Clinical Insights on the Long-Term Efficacy, Safety Profile of Bexicaserin in Developmental Epileptic Encephalopathies: Johannes Streffer, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Clears KORU FreedomEDGE System to Administer Rozanolixizumab-noli in gMG

Women Physicians Day 2026: Supporting Women With MS Through Reproductive and Life Stage Transitions

Anti-IL6R Therapy Effective in Reducing NMOSD and MOGAD Disease Activity

Taysha Doses First Patient in Pivotal Trial for Rett Syndrome Gene Therapy TSHA-102, Aligns With FDA on BLA Plans

Clinical Considerations for Pharmacologic Approaches to Functional Seizures: Benjamin Tolchin, MD, FAAN